|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06108 NEW RAY MEDIC
Nominal 
0.385 0.000 (0.000%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 44,701 | 167.382% | 93,945 | 50,154 | 89,771 | 335,380 |
| Cost of Sales | (41,065) | 291.393% | (82,453) | (37,213) | (76,523) | (306,892) |
| Gross Profit | 3,636 | -41.600% | 11,492 | 12,941 | 13,248 | 28,488 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 682 | -- | 3,925 | 423 | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 1,110 | |
| Profit / (Loss) before Taxation | (7,454) | 82.562% | (32,060) | (22,342) | (80,286) | (3,608) | |
| Taxation | 0 | -- | 1,047 | 172 | 2,339 | 784 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (7,454) | 82.339% | (31,013) | (22,170) | (77,947) | (2,824) | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (313) | -76.143% | (1,869) | (2,936) | (2,715) | (931) |
| Depreciation & Amortisation | 3,858 | 18.635% | 6,804 | 9,767 | 10,173 | 9,603 |
| Directors' Emoluments | -- | -- | 3,083 | 3,080 | 5,053 | 2,923 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Qualified | Qualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -4.500 | 87.500% | -18.600 | -13.300 | -46.600 | -1.700 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.029) | (0.272) | 0.000 | (0.035) |
| NBV per share ($) | 2.538 | -- | 2.817 | 2.873 | 3.14417 | 3.783672 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -7,454 |
| %Change | 82.339% |
| EPS / (LPS) | HKD -0.045 |
| NBV Per Share ($) | HKD 2.538 |